Albem1(cre/ERT2)Bcgen
Endonuclease-mediated Allele Detail
|
Symbol: |
Albem1(cre/ERT2)Bcgen |
Name: |
albumin; endonuclease-mediated mutation 1, Biocytogen LLC |
MGI ID: |
MGI:7490209 |
Synonyms: |
ERT2-Alb-Cre |
Gene: |
Alb Location: Chr5:90608756-90624461 bp, + strand Genetic Position: Chr5, 44.7 cM
|
Alliance: |
Albem1(cre/ERT2)Bcgen page
|
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Endonuclease-mediated (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Not Specified
|
|
|
Albem1(cre/ERT2)Bcgen expression driven by
1 gene
Knock-in expression driven by:
Organism |
Driver Gene |
Note |
mouse |
Alb (MGI:87991) |
|
|
|
|
No molecular details were provided. (J:329211)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Alb
(mouse)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Alb Mutation: |
91 strains or lines available
|
|
Original: |
J:329211 Liu F, et al., Oncogenic beta-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer. Proc Natl Acad Sci U S A. 2022 Sep 27;119(39):e2202157119 |
All: |
1 reference(s) |
|